Lead

Australia's medicines regulator has escalated its response to the growing market of unregulated peptide products, while the federal government has announced a significant funding boost for arthritis research. The Therapeutic Goods Administration (TGA) has placed unapproved peptides among its priority focus areas, citing risks to consumer safety from what it describes as unlawful drugs.

The move comes as the TGA, along with the Australian Border Force and Victoria Police, conducted seizures of peptides and other substances with an estimated street value of over $2 million in April. The regulator said responses to unlawful importation, supply, manufacturing, or advertising may include product seizures, infringement notices, and civil or criminal penalties where appropriate.

Coverage Comparison

Reports from ABC Australia and The Guardian (World edition) both highlighted the TGA's crackdown on illegal peptides, though with different emphases. ABC Australia focused on the consumer safety risks and the role of social media influencers in promoting these products. The Guardian's coverage similarly noted the regulatory response, but framed it as part of broader government actions, including the new arthritis research funding.

Both outlets quoted TGA chief Prof Anthony Lawler, who said, "As the availability of unapproved peptide products has increased, so too has evidence of potential risk to consumers." The Guardian's report also mentioned a "surge in imports and online advertising" as a key driver of the regulator's actions.

Key Claims

  • The TGA has included unapproved peptides in its priority focus areas, alongside products like weight loss medications, vapes, and sunscreens, according to reports from ABC Australia and The Guardian.
  • Social media influencers are increasingly promoting unregulated peptides, often hyping them as performance-enhancing or marketing them for weight loss or anti-aging, as reported by both outlets.
  • Examples of unapproved peptide products cited by ABC Australia include Melanotan II, retatrutide, BPC157, GHK-Cu, TB500, and CJC-1295.
  • The TGA issued a safety alert in April warning of severe allergic reactions and other health risks associated with unregulated peptides, as reported by ABC Australia.
  • The TGA, Australian Border Force, and Victorian Police seized peptides and other substances with an estimated street value of over $2 million, as noted in both ABC Australia and The Guardian.
  • The federal government will spend an extra $100 million over 10 years for arthritis research, according to The Guardian's report.

Claims and Perspectives

Prof Anthony Lawler, the TGA's chief, described the crackdown as a "deliberate, risk-based response" to an evolving peptides market. The Australian Medical Association's public health committee chair, Dr Michael Bonning, praised the move as the "strongest action the TGA has taken on peptides," adding that "when the TGA takes action, it has real results in terms of curbing behaviours and stopping people from profiteering off lies and dodgy science."

On the arthritis funding, Prime Minister Anthony Albanese said, "For millions of Australians, living with arthritis isn't just an ache or pain, it affects their ability to work, to stay active and to enjoy everyday life." The funding, part of the government's Medical Research Future Fund, will support a new arthritis and musculoskeletal conditions research mission aimed at improving prevention, diagnosis, and treatment.

Perspectives

  • Regulator's perspective: The TGA views unregulated peptides as a growing consumer safety threat, requiring increased enforcement and public warnings.
  • Government's perspective: The federal government frames the $100 million arthritis research investment as a life-changing commitment to improving health outcomes for millions of Australians.
  • Medical community's perspective: The Australian Medical Association supports the TGA's aggressive stance, seeing it as a necessary step to curb misleading promotions and protect public health.